Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health Initiative

Drug repurposing as an alternative to costly drugs such as herceptin in breast cancer

Quality of life and cost advantages of metronomics and drug repurposing

Diabetes drug, metformin, repurposed for use against several cancers including breast

Betablockers repurposed to treat neuroblastoma

Industry view of targeted therapy combinations in oncology

Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination

Networking and collaborating across borders in sub-Saharan Africa

Genomic complexity of metastatic disease and the conundrum of combinations

Complexity of intra- and inter-pathway loops in colon cancer and melanoma: Implications for targeted therapies

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care

Systems medicine approach to optimise drugs and drug combinations for individual AML patients